APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells

被引：0
|
作者：
Mingjue Chen
Tetsuo Mashima
Taichi Oishi
Yukiko Muramatsu
Yosuke Seto
Manabu Takamatsu
Naomi Kawata
Shun Morino
Ayane Nakamura
Saori Inaba
Xunmei Yuan
Kohei Maruyama
Mai Suzuki
Ayana Sato
Haruka Yoshida
Myung-Kyu Jang
Anna Mizutani
Kengo Takeuchi
Kensei Yamaguchi
Fumiyuki Shirai
Satoshi Nagayama
Ryohei Katayama
Hiroyuki Seimiya
机构：
[1] Japanese Foundation for Cancer Research (JFCR),Division of Molecular Biotherapy, Cancer Chemotherapy Center
[2] The University of Tokyo,Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences
[3] Cancer Chemotherapy Center,Division of Experimental Chemotherapy
[4] JFCR,Division of Pathology
[5] The Cancer Institute,Gastroenterological Chemotherapy
[6] JFCR,Graduate School of Pharmaceutical Sciences
[7] Cancer Institute Hospital,Drug Discovery Chemistry Platform Unit
[8] JFCR,Gastroenterological Surgery
[9] Meiji Pharmaceutical University,Department of Surgery
[10] RIKEN Center for Sustainable Resource Science,undefined
[11] Cancer Institute Hospital,undefined
[12] JFCR,undefined
[13] Uji-Tokushukai Medical Center,undefined
来源：
British Journal of Cancer | 2024年 / 130卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：151 / 162
页数：11
相关论文
共 50 条
  • [1] APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells
    Chen, Mingjue
    Mashima, Tetsuo
    Oishi, Taichi
    Muramatsu, Yukiko
    Seto, Yosuke
    Takamatsu, Manabu
    Kawata, Naomi
    Morino, Shun
    Nakamura, Ayane
    Inaba, Saori
    Yuan, Xunmei
    Maruyama, Kohei
    Suzuki, Mai
    Sato, Ayana
    Yoshida, Haruka
    Jang, Myung-Kyu
    Mizutani, Anna
    Takeuchi, Kengo
    Yamaguchi, Kensei
    Shirai, Fumiyuki
    Nagayama, Satoshi
    Katayama, Ryohei
    Seimiya, Hiroyuki
    BRITISH JOURNAL OF CANCER, 2024, 130 (01) : 151 - 162
  • [2] APC/PIK3CA mutations and active ß-catenin level as biomarkers of tankyrase inhibitor sensitivity in colorectal cancer
    Mashima, Tetsuo
    Chen, Mingjue
    Oishi, Taichi
    Muramatsu, Yukiko
    Seto, Yosuke
    Takamatsu, Manabu
    Kawata, Naomi
    Morino, Shun
    Nakamura, Ayane
    Inaba, Saori
    Yamaguchi, Kensei
    Shirai, Fumiyuki
    Nagayama, Satoshi
    Katayama, Ryohei
    Seimiya, Hiroyuki
    CANCER SCIENCE, 2025, 116 : 1877 - 1877
  • [3] Evaluation of predictive biomarkers for tankyrase inhibitor sensitivity using patient-derived colorectal cancer cells
    Chen, Mingjue
    Mashima, Tetsuo
    Muramatsu, Yukiko
    Shimizu, Yuki
    Nagayama, Satoshi
    Katayama, Ryohei
    Seimiya, Hiroyuki
    CANCER SCIENCE, 2022, 113 : 927 - 927
  • [4] Novel mouse model carrying APC and PIK3CA mutations in colorectal cancer
    Khan, Naghma
    Jajeh, Farah
    Eberhardt, Emily L.
    Miller, Devon D.
    Albrecht, Dawn M.
    Van Doorn, Rachel
    Hruby, Melissa D.
    Maresh, Morgan E.
    Clipson, Linda
    Mukhtar, Hasan
    Halberg, Richard B.
    CANCER RESEARCH, 2019, 79 (13)
  • [5] Aspirin and PIK3CA Mutations in Colorectal Cancer
    Kirstein, M. M.
    Vogel, A.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (03): : 306 - 307
  • [6] The Landscape of PIK3CA Mutations in Colorectal Cancer
    Voutsadakis, Ioannis A.
    CLINICAL COLORECTAL CANCER, 2021, 20 (03) : 201 - 215
  • [7] Patient-derived organoid models of metastatic colorectal cancer to study response to PIK3CA inhibitors
    Barros Silva, J. D.
    Wanigasooriya, K.
    Bermingham, H.
    Patel, S.
    Hoare, R.
    Stodolna, A.
    Pickles, O.
    Bryer, C.
    Whalley, C.
    Beggs, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [8] MEN1611 in combination with cetuximab: Targeting PIK3CA mutations in RAS-wild-type patient-derived colorectal cancer xenografts
    Capano, S.
    Merlino, G.
    Bigioni, M.
    Tunici, P.
    Cottino, F.
    Zanella, E.
    Vurchio, V.
    Bertotti, A.
    Trusolino, L.
    Laurent, D. O.
    Pellacani, A.
    Binaschi, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S573 - S573
  • [9] PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells
    Higgins, Michaela J.
    Beaver, Julia A.
    Wong, Hong Yuen
    Gustin, John P.
    Lauring, Josh D.
    Garay, Joseph P.
    Konishi, Hiroyuki
    Mohseni, Morassa
    Wang, Grace M.
    Cidado, Justin
    Jelovac, Danijela
    Cosgrove, David P.
    Tamaki, Akina
    Abukhdeir, Abde M.
    Park, Ben Ho
    CANCER BIOLOGY & THERAPY, 2011, 11 (03) : 358 - 367
  • [10] Activation of WNT/β-catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations
    Park, Ye-Lim
    Kim, Hwang-Phill
    Cho, Young-Won
    Min, Dong-Wook
    Cheon, Seul-Ki
    Lim, Yoo Joo
    Song, Sang-Hyun
    Kim, Sung Jin
    Han, Sae-Won
    Park, Kyu Joo
    Kim, Tae-You
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (02) : 389 - 401
12345